Search clinical trials for: PRT064445/Rivaroxaban

Total 483 results

Beijing Anzhen Hospital

Unknown

Rivaroxaban in Patients With Atrial Fibrillation and Coronary Artery Disease Undergoing Percutaneous Coronary Intervention

Atrial Fibrillation

China
Bayer
Janssen Research & Development, LLC

Completed

A Study to Gather Information About Rivaroxaban in Patients in Sweden With Cancer Who Also Have Thrombosis (OSCAR-SE)

Treatment of Venous Thromboembolism in Cancer Patients

Sweden
Christian Torp-Pedersen
Odense University Hospital; Aarhus University Hospital; Rigshospitalet, Denmark; Aalborg University Hospital

Unknown

Rivaroxaban or Aspirin for Biological Aortic Prosthesis

Thrombosis | Aortic Stenosis | Aortic Regurgitation

Denmark
Brigham and Women's Hospital
Harvard Medical School (HMS and HSDM); Patient-Centered Outcomes Research Institute

Enrolling by invitation

The DARE Warfarin CER Study

Pulmonary Embolism | Deep Venous Thrombosis

United States
Sheffield Teaching Hospitals NHS Foundation Trust

Completed

WILL lOWer Dose Aspirin be Better With Rivaroxaban in Patients With Chronic Coronary Syndromes? (WILLOW CCS)

Coronary Syndrome

United Kingdom
Bayer

Completed

A Study to Collect Data on the Treatment Pattern of Xarelto + Acetylsalicylic Acid in the Routine Clinical Practice in Patients Who Are Suffering From a Condition That Narrows the Blood Vessels Supplying the Heart and / or a Condition That Most Commonly Narrows the Blood Vessel in the Legs (XATOC)

Coronary Artery Disease | Peripheral Artery Disease

Spain, Belgium, Italy, Korea, Republic of, Russian Federation, Taiwan, China, Colombia, Switzerland, Slovenia
Maatschap Cardiologie Zwolle
Diagram B.V.

Completed

Rivaroxaban Plus Aspirin in Patients With Chronic Coronary Syndrome and High Ischemic Risk

Coronary Artery Disease (CAD) | Peripheral Arterial Disease (PAD)

Netherlands
Shiraz University of Medical Sciences

Completed

Rivaroxaban Post Coronary Bypass Surgery

Post Coronary Bypass Surgery Patients

Iran, Islamic Republic of
Population Health Research Institute
University of Cape Town

Withdrawn

INVestIgation of rheumatiC AF Treatment Using Vitamin K Antagonists, Rivaroxaban or Aspirin Studies, Superiority (INVICTUS-ASA)

Rheumatic Heart Disease
LifeBridge Health
Janssen Scientific Affairs, LLC

Unknown

Synergistic Influence of Rivaroxaban on Inflammation and Coagulation Biomarkers in Patients With CAD and PAD on Aspirin Therapy

Coronary Artery Disease | Peripheral Artery Disease

United States
Xijing Hospital

Unknown

Treatment of Rivaroxaban Versus Aspirin for Non-disabling Cerebrovascular Events (TRACE)

Ischemic Stroke | TIA

China
Brigham and Women's Hospital

Completed

Replication of the ROCKET-AF Anticoagulant Trial in Healthcare Claims Data

Atrial Fibrillation

United States
Hospital Universitari Vall d'Hebron Research Institute

Completed

Rivaroxaban for Patients With Antiphospholipid Syndrome

Antiphospholipid Syndrome

Spain
Ottawa Hospital Research Institute
Canadian Institutes of Health Research (CIHR); Canadian Venous Thromboembolism...

Recruiting

COmparison of Bleeding Risk Between Rivaroxaban and Apixaban in Patients With Atrial Fibrillation (COBRRA-AF)

Atrial Fibrillation

Canada
Ottawa Hospital Research Institute
Canadian Institutes of Health Research (CIHR); Canadian Venous Thromboembolism...

Completed

Comparison of Bleeding Risk Between Rivaroxaban and Apixaban (COBRRA Pilot)

Venous Thromboembolism

Canada
Perosphere Pharmaceuticals Inc, a wholly owned...

Completed

Phase 2 Study of Rivaroxaban Reversal by Ciraparantag as Measured by WBCT

Healthy

United States
The Second Affiliated Hospital of Chongqing Medical...

Not yet recruiting

A Trial of Rivaroxaban Versus Warfarin in Dissolving Left Atrial Appendage Thrombus in Patients With Atrial Fibrillation

Atrial Fibrillation | Left Atrial Appendage Thrombosis | Rivaroxaban
Brigham and Women's Hospital

Completed

Prediction of the COBRRA AF Anticoagulant Trial in Healthcare Claims Data

Atrial Fibrillation

United States
Daiichi Sankyo UK Ltd, a Daiichi Sankyo Company

Completed

Study to Evaluate the Use of Direct Oral Anticoagulants in UK Clinical Practice For Patients With a First Stroke Attributable to Nonvalvular Atrial Fibrillation

Atrial Fibrillation

United Kingdom
Hospital do Servidor Publico Estadual

Unknown

Comparison Between Xarelto Versus Warfarin in the Recanalization Rate of Deep Venous Thrombosis in Patients Legs. (DVT)

Deep Venous Thrombosis

Brazil
McMaster University

Terminated

Rivaroxaban for Treatment of Patients With Suspected or Confirmed Heparin-Induced Thrombocytopenia

Heparin-induced Thrombocytopenia

Canada
Pirogov Russian National Research Medical University

Completed

Rivaroxaban With Diosmin in Long-term Treatment of Deep Vein Thrombosis (RIDILOTT-DVT)

Deep Vein Thrombosis | Postthrombotic Syndrome

Russian Federation
Zagazig University

Completed

Efficacy and Safety of Rivaroxaban in Acute Non-neoplastic Portal Vein Thrombosis in HCV

Portal Vein Thrombosis
Assistance Publique - Hôpitaux de Paris

Completed

Benefit/Risk in Real Life of New Oral Anticoagulants and Vitamin K Antagonists in Patients Aged 80 Years and Over (PRESAGE-ACO)

Atrial Fibrillation

France
Inari Medical

Recruiting

DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis (DEFIANCE)

Venous Thromboembolism | Deep Venous Thrombosis | Post-Thrombotic Syndrome

United States, Germany, Finland, Switzerland, United Kingdom
Bayer

Active, not recruiting

Study to Learn More About the Safety and Effectiveness of Rivaroxaban (Xarelto) When Given Together With Acetylsalicylic Acid to Indian People With Narrowing of the Arteries of the Heart (CAD) and/or With Reduced Blood Flow in the Arteries of the Legs and Arms With Symptoms (Symptomatic PAD)

Coronary Artery Disease (CAD) | Prevention of Atherothrombotic Events | Symptomatic Peripheral Artery Disease (Symptomatic PAD)

India
Hanyang University Seoul Hospital

Completed

Comparative Study of Prophylactic Agent for Venous Thromboembolism After Total Knee Arthroplasty

Venous Thromboembolism

Korea, Republic of
Medical University of Vienna

Completed

Antithrombotic Triple Therapy in Humans

Atrial Fibrillation | Acute Coronary Syndrome

Austria
Chang Gung Memorial Hospital

Unknown

Comparison of Topical and Infusion Tranexamic Acid After Total Knee Arthroplasty

Osteoarthritis, Knee

Taiwan
Scotmann Pharmaceuticals
Rawalpindi Medical College

Not yet recruiting

Efficacy and Safety of Apixaban in COVID-19 Coagulopathy Patients With Respiratory Severity Under Critical Care (ECRU)

COVID-19

Pakistan
Isfahan University of Medical Sciences

Unknown

Efficacy Comparison of Warfarin Versus Rivaroxaban CVT

Cerebral Venous Thrombosis

Iran, Islamic Republic of
Huashan Hospital

Unknown

Study of Prophylactic Effect of Rivaroxaban on Venous Thromboembolism in AECOPD (SUPREME)

Venous Thromboembolism | Acute Exacerbation Copd

China
Yokohama City University Medical Center
Yokohama City University

Unknown

Anti-inflammatory Effects of Rivaroxaban Versus Dabigatran (RIVAL-AF)

Atrial Fibrillation

Japan
Shahid Gangalal National Heart Centre

Recruiting

Anticoagulation in Post MI LV Thrombus Trial in Nepal (WaRMIN)

Myocardial Infarction | Left Ventricular Thrombus

Nepal
Ottawa Hospital Research Institute
Canadian Institutes of Health Research (CIHR); Canadian Venous Thromboembolism...

Recruiting

Comparison of Bleeding Risk Between Rivaroxaban and Apixaban for the Treatment of Acute Venous Thromboembolism (COBRRA)

Venous Thromboembolism

Canada, Australia, Ireland
University Hospital, Montpellier

Completed

Better Adherence With New Oral Anticoagulant in Atrial Fibrillation : Effectiveness of a Personalized Education Program (MONACO)

Non-valvular Atrial Fibrillation

France
IHF GmbH - Institut für Herzinfarktforschung
OrbusNeich

Withdrawn

COMBO-Stent in Patients on Chronic Anticoagulant Therapy (COSTA) COSTA-Bleed and COSTA-Outcome Trials (COSTA)

Coronary Disease | Stable Angina | Unstable Angina | STEMI | NSTEMI

Germany
Ottawa Heart Institute Research Corporation
Bristol-Myers Squibb; Bayer; Boehringer Ingelheim; Heart and Stroke Foundation...

Completed

Strategy of Continued Versus Interrupted Novel Oral Anti-coagulant at Time of Device Surgery in Patients With Moderate to High Risk of Arterial Thromboembolic Events (BRUISECONTROL2)

Hematoma

Canada, Israel
University of Texas at Austin
University of Kansas

Not yet recruiting

Restart TICrH Alpha Pilot Protocol, Restarting DOACs After Traumatic Intracranial Hemorrhage

Anticoagulants; Increased
Bristol-Myers Squibb

Completed

Real-World Comparative Observational Study in Non-Valvular Atrial Fibrillation Patients Using Oral Anticoagulants

Atrial Fibrillation
AIO-Studien-gGmbH
Bayer; Charite University, Berlin, Germany

Terminated

Rivaroxaban in the Treatment of Venous Thromboembolism (VTE) in Cancer Patients

Cancer | Venous Thromboembolism

Germany
Chang Gung Memorial Hospital

Completed

Combined Topical Tranexamic Acid With Floseal® in Total Knee Arthroplasty

Osteoarthritis, Knee

Taiwan
Vanderbilt University Medical Center
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

The Impact of Factor Xa Inhibition on Thrombosis, Platelet Activation, and Endothelial Function in Peripheral Artery Disease

Peripheral Arterial Disease

United States
Bayer
Janssen, LP

Completed

Study to Gain Insights in Treatment Patterns and Outcomes in Patients With Atherosclerosis Prescribed to Xarelto in Combination With Acetylsalicylic Acid (XATOA)

Atherosclerosis

Germany, Argentina, Brazil, Canada, Denmark, Israel, Korea, Republic of, Lebanon, Luxembourg, Mexico, Norway, Russian Federation, Slovenia, Sweden, Switzerland, Thailand, United Arab Emirates, United Kingdom
University College, London
King's College Hospital NHS Trust; University College London Hospitals; Barts... and other collaborators

Active, not recruiting

RIvaroxaban for Stroke Patients With AntiPhospholipid Syndrome (RISAPS)

Stroke | Ischemic Stroke | Brain Ischemia | Systemic Lupus Erythematosus | Antiphospholipid Syndrome

United Kingdom
Kyunghee University Medical Center

Unknown

Pleotropic Effect of New Oral Anticoagulants

Atrial Fibrillation

Korea, Republic of
Charite University, Berlin, Germany
Bayer; Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)

Terminated

Effect of Anticoagulation Therapy on Clinical Outcomes in COVID-19 (COVID-PREVENT)

COVID-19

Germany
Northwestern University

Completed

Tolerance of Chlorhexidine Gluconate Vaginal Cleansing Solution

Surgical Preparation of the Vagina

United States
Stéphane Zuily
International Society on Thrombosis and Haemostasis

Recruiting

International Registry of Thrombotic APS Patients Treated With Direct Oral Anticoagulants (OBSTINATE)

Thrombosis | Antiphospholipid Syndrome | Anticoagulants Causing Adverse Effects in Therapeutic Use

France
Fondazione per la Ricerca Ospedale Maggiore

Completed

Use of Direct Oral Anticoagulants (DOACs) in Patients With Ph-negative Myeloproliferative Neoplasms (MPN-DOACs)

Myeloproliferative Neoplasm

Italy, United Kingdom, Germany, France, United States, Spain, Canada

Search clinical trials for: PRT064445/Rivaroxaban

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Lebanon

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations